The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index; 17 of the 42 sources its claims cite were checked for support.
EMDR treatment for anxiety in MS patients: A pilot study
Open accessAbstract
Background: Patients with multiple sclerosis (MS) often experience high levels of anxiety, specifically about the (unpredictable) future related to MS. Worries about physical and cognitive declines can cause frightening mental representations of future ‘worst-case scenarios’. Evidence of the applicability of eye movement desensitization reprocessing (EMDR) using flash-forward on anxiety is growing. Objective: This pilot study examines the flash-forward EMDR procedure as a treatment option in MS patients suffering from anxiety specifically related to future MS problems. Methods: Eight MSpatients suffering from anxiety were treated with one to three sessions of EMDR with a flash-forward target. Treatment effects were evaluated with the use of questionnaires on anxiety, depression, worry, cognitive avoidance, and quality of life at three time points: pre-treatment, direct post-treatment, and three-month follow-up. Results: Significant improvement was shown post-treatment compared to pre-treatment on anxiety, depression, and worry. In a case series analysis, all but one participant showed a clinically important difference in anxiety. Conclusion: Before implementation on a larger scale can be recommended, the value of EMDR with flash forward targets for anxiety in MS need to be further examined. However, the positive results on this pilot can be seen as promising and motivation for future studies. © The Author(s) 2020.
Overview
CoChat Summary
TL;DR
This pilot study tested flash-forward EMDR for MS patients whose anxiety was tied to feared future MS scenarios. In 8 treated participants, anxiety, depression, and worry improved after treatment, but the study was very small and lacked a control group.
Key findings
- Eight MS/CIS patients received 1 to 3 EMDR sessions using a flash-forward target; all but one showed a clinically important anxiety improvement by the paper’s MCID criterion.
- Pre- vs post-treatment, there were significant improvements in anxiety (HADS-A), depression (HADS-D), total HADS, and worry (PSWQ); cognitive avoidance (CAQ) and quality of life (WHOQOL-BREF) did not change significantly.
- The paper reports that treatment effects were stable at 3-month follow-up: no significant changes were found between the post-treatment and follow-up time points.
- Effect sizes were reported as “very large” for HADS-A, HADS-D, and HADS, and “large” for PSWQ.
Methods
- Pilot intervention study in 8 patients with multiple sclerosis or clinically isolated syndrome and anxiety related to future MS problems; participants were treated at the Department of Medical Psychology at ETZ in Tilburg, the Netherlands.
- Treatment consisted of up to 3 EMDR sessions, each up to 90 minutes, using the standardized flash-forward protocol; participants identified up to 3 worst-case future scenarios as targets.
- Outcomes were measured at baseline, within 2 weeks after the last session, and 3 months later using HADS-A (primary), HADS-D, PSWQ, CAQ, and WHOQOL-BREF; analyses used paired t-tests, Cohen’s d, and MCID for individual change.
Limitations
- The paper explicitly states the main limitations were the small sample size and lack of a control group, which prevented filtering out nonspecific effects or spontaneous recovery.
- The paper also states the sample was not representative, because participants came from multidisciplinary MS care at one hospital and many may already have received treatment for anxiety.
- Evident from the text: one of the 8 remaining participants did not complete follow-up questionnaires, so follow-up analyses were based on incomplete data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
13 Valid · 3 Not valid · 17 Not checked · 28 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“In sum, some form of CBT is the only evidence-based treatment to reduce anxiety in people with MS.”
§ EMDR treatment for anxiety in MS patients: A pilot study > Introduction > Treatment options for anxiety in MS
What the sources say
- Not checked — no full text of the sourcecites [10] source
- Disputedcites [11] sourceExperimental — accuracy not yet measured
The Background says mindfulness-based interventions (MBIs) operate differently from CBT. The Results (Table 4) report a statistically significant reduction in anxiety after an MBI in people with MS, sustained at six months. The paper therefore does not support the claim that some form of CBT is the only evidence-based treatment for reducing anxiety in this population. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [12] source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the results on the reduction of anxiety are mixed, and treatment usually consists of eight to 11 sessions.”
§ EMDR treatment for anxiety in MS patients: A pilot study > Introduction > Treatment options for anxiety in MS
What the sources say
- Not checked — no full text of the sourcecites [10] source
- Partly supportedcites [11] sourceExperimental — accuracy not yet measured
The Results > Outcomes section reports mixed anxiety findings in people with MS: one mindfulness-based intervention study found a significant reduction, while another found a non-significant change. These findings concern mindfulness-based interventions, not CBT. The Results > Intervention characteristics section describes six, eight, or approximately nine sessions, not a usual course of eight to 11 CBT sessions; page numbers are unavailable in our copy. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [12] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The positive treatment effect on anxiety and depression symptoms is in line with results of EMDR treatment for anxiety in glioblastoma multiforme patients,21 and patients undergoing hemodialyses.22”
§ EMDR treatment for anxiety in MS patients: A pilot study > Discussion
What the sources say
- Supportedcites [21] source
Citation 21 supports the glioblastoma portion of the sentence, not the separately cited hemodialysis portion. The Results report statistically significant decreases in anxiety and depression symptoms after EMDR compared with the control group; the Discussion identifies the sample as female patients with glioblastoma. (LLM, conf=0.93)
- Supportedcites [22] source
The citation to this paper follows the hemodialysis-patient portion of the sentence, not the glioblastoma portion. The Discussion (§4) reports reduced anxiety and depression scores in the EMDR intervention group, and the Conclusion (§5) states that EMDR had positive effects on both outcomes in patients undergoing hemodialysis. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Significant improvement was shown post-treatment compared to pre-treatment on anxiety, depression, and worry.”
- Also stated in: § Treatment outcomes · plain
“Significant improvement is shown before (Time0) and after treatment (Time2), not only in terms of the primary outcome scores of the HADS-A, but also for those on the HADS-D, HADS total, and PSWQ.”
§ EMDR treatment for anxiety in MS patients: A pilot study > Abstract > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Treatment outcomes · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Significant improvement was shown post-treatment compared to pre-treatment on anxiety, depression, and worry.”
- Also stated in: § Treatment outcomes · plain
“Significant improvement is shown before (Time0) and after treatment (Time2), not only in terms of the primary outcome scores of the HADS-A, but also for those on the HADS-D, HADS total, and PSWQ.”
§ EMDR treatment for anxiety in MS patients: A pilot study > Abstract > Results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Treatment outcomes · plain
25 more claims
Create a free account to see all 61 claims and every source verdict.
- Probably not a substantial claim. 25
- It may state two separate claims as one. 15
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Encouraging data in adults with clinical anxiety problems showed reduced anxiety symptoms after using EMDR with prospective images of feared catastrophe, for instance in anxiety related to the course of a degenerative disease (Wallis and de Vries 2020) and fear of childbirth (Baas et al. 2022).”
From Negative Flashforward Imagery in Adolescent Social Anxiety Disorder: A Pilot Study of Imagery Reports and a Short EMDR Intervention. (2024) · cites this paper as Wallis and de Vries 2020
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ EMDR treatment for anxiety in MS patients: A pilot study > Results > Treatment outcomes
“Scores on the questionnaires at Time2 were compared with the scores at Time3. As can be seen in Table 3, no significant changes were found in the scores on the questionnaires between both time points.”
§ EMDR treatment for anxiety in MS patients: A pilot study > Methods > Measurements
“A baseline measurement was performed after the interview with the main researcher (Time0). The same measurement was repeated within two weeks after the last treatment (Time1) and then three months after the last treatment (Time2).”
Citations
Cites
Statistical Power Analysis for the Behavioral Sciences
Muller, K. (1989) · Technometrics · doi:10.1080/00401706.1989.10488618 · Cited by 99,167
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802 · cited 1×
“MS was diagnosed using the McDonald criteria of 2010.(23) In one case, the MS criteria was not met, and the patient was diagnosed with CIS.”
MethodDevelopment and validation of the Penn State Worry Questionnaire
Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990) · Behaviour Research and Therapy · doi:10.1016/0005-7967(90)90135-6 · Cited by 5,099 · cited 1×
“The PSWQ has been found to be a valid instrument for assessing worry, and the test-retest reliability is adequate.(28) Although there is not a norm group specific for MS or neurological patients, the PSWQ was used to examine worry in MS.”
MethodNew Multiple Sclerosis Phenotypic Classification
Lublin, F. D. (2014) · European Neurology · doi:10.1159/000367614 · Cited by 4,259
Herrmann, C. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(96)00216-4 · Cited by 2,885 · cited 1×
“The HADS not only gives clinically meaningful results as a psychological screening tool, but is also sensitive to changes in response to psychotherapeutic intervention.(26) HADS scores for Time0 were obtained from the inclusion procedures.”
MethodKappos, L., Polman, C. H., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Jakobs, P., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000237641.33768.8d · Cited by 681
Puhan, M. A., Frey, M., Büchi, S., & Schünemann, H. J. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-46 · Cited by 586
Kappos, L., Polman, C. H., Freedman, M. S., Edan, G., Hartung, H. P., Miller, D. H., Montalban, X., Barkhof, F., Bauer, L., Jakobs, P., et al. (2007) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2006.11.003 · Cited by 549
Validation of the Hospital anxiety and depression scale for use with multiple sclerosis patients
Honarmand, K., & Feinstein, A. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458509347150 · Cited by 436 · cited 1×
“Previous studies have used different cut-off scores ranging from eight or higher to 11 or higher to classify anxiety.(34) However, patient 5 started with an anxiety score of nine, but did benefit from treatment, thus supporting the cut-off value used here.”
MethodAnxiety disorders and their clinical correlates in multiple sclerosis patients
Korostil, M., & Feinstein, A. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506071161 · Cited by 424 · cited 1×
“9%).(6) Early diagnosis and treatment of anxiety is essential.”
Background
Research works printed but not linked: 3
- Bayati A, 2017, Iioab J, 8, 82
- de Jongh A, 2006, Een geprotocolleerde behandelmethode voor de gevolgen van psychotrauma
- Gosselin P, 2002, Ournal de Therapie Comportementale et Cognitive, 12, 24
Cited by
Driessen, H. P. A., Morsink, S., Busschbach, J. J. V., Hoogendijk, W. J. G., & Kranenburg, L. W. (2024) · European Journal of Psychotraumatology · doi:10.1080/20008066.2024.2341577 · Cited by 23
Conijn, T., Haverman, L., Wijburg, F. A., & de Roos, C. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01768-7 · Cited by 12
“Our data also reveals the importance of identifying flash forward representations related to future ‘worst-case scenarios’, which was also recently highlighted in a pilot study on the effect of EMDR in multiple sclerosis patients [31].”
BackgroundThe EMDR Recent Traumatic Episode Protocol With an Intensive Care Survivor: A Case Study
Clarke, R. (2022) · Journal of EMDR Practice and Research · doi:10.1891/emdr-2021-0028 · Cited by 9
Williams, T. R., Lynch, E., Jones, P., Bass, J. E., & Harrison, R. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.103911 · Cited by 7
Thunnissen, M. R., de Jong, P. J., Weijermans, J., Vet, L. J. J., Rijkeboer, M. M., & Nauta, M. H. (2024) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.3063 · Cited by 6
Metadata
- Authors
- Wallis, O. C., & de Vries, J.
- Affiliations
- Elisabeth-TweeSteden Ziekenhuis (NL)
- Department of Medical Psychology, ETZ Hospital, Tilburg, the Netherlands
- Corresponding author
- Wallis, Olga C
- ORCID
- Wallis, Olga C
- Venue
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
- Publisher
- SAGE Publications
- Published
- 2020-10
- Volume
- 6
- Issue
- 4
- Pages
- 2055217320974388-2055217320974388
- ISSN
- 2055-2173 (ISSN-L)
- PMC
- PMC7780185
- OpenAlex
- W3114920833
- Semantic Scholar
- a15462d92f46845f02102b114599b32372a8fd42
- Cited by
- 16
- References
- 34
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 3 · 2021: 1
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Multiple Sclerosis Journal - Experimental Translational and Clinical (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Keywords
- EMDR, multiple sclerosis, anxiety, worry, depression, cognitive avoidance, quality of life, psychotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: EMDR treatment for anxiety in MS patients: A pilot study. https://app.cochat.ai/papers/10.1177/2055217320974388
- The paper
- Wallis, O. C., & de Vries, J. (2020). EMDR treatment for anxiety in MS patients: A pilot study. Multiple Sclerosis Journal - Experimental, Translational and Clinical. https://doi.org/10.1177/2055217320974388
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.